Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bertolami

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|October 26, 2000
Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemiaL A Salazar, S A Cavalli, M H Hirata, et al.
Arquivos Brasileiros De Cardiologia|June 6, 2006
[Lipid profile and nutrition counseling effects in adolescents with family history of premature coronary artery disease]Gislaine A Mendes, Tania L Martinez, Maria C Izar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 14, 2000
Apolipoprotein B gene polymorphisms: prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from BrazilS A Cavalli, M H Hirata, L A Salazar, et al.
International Journal of Clinical and Experimental Medicine|July 2, 2015
Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot studyTomás Zambrano, Mario Hiroyuki Hirata, Álvaro Cerda, et al.
Clinical Cardiology|December 3, 2003
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroupsMichael H Davidson, Leiv Ose, Jiri Frohlich, et al.
Human Mutation|April 5, 2002
Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutationsLuis A Salazar, Mario H Hirata, Selma A Cavalli, et al.
Clinical Chemistry and Laboratory Medicine|November 29, 2005
APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individualsSimone C Sorkin, Francisco J Forestiero, Mario H Hirata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 7, 2013
Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal womenAlvaro Cerda, Mustafa H Issa, Fabiana D V Genvigir, et al.
Journal of Clinical Lipidology|May 6, 2014
Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjectsJacqueline M Anderson, Alvaro Cerda, Mario H Hirata, et al.
JAMA|June 22, 2002
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trialPatrick W J C Serruys, Pim de Feyter, Carlos Macaya, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|October 26, 2000
Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemiaL A Salazar, S A Cavalli, M H Hirata, et al.
Arquivos Brasileiros De Cardiologia|June 6, 2006
[Lipid profile and nutrition counseling effects in adolescents with family history of premature coronary artery disease]Gislaine A Mendes, Tania L Martinez, Maria C Izar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 14, 2000
Apolipoprotein B gene polymorphisms: prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from BrazilS A Cavalli, M H Hirata, L A Salazar, et al.
International Journal of Clinical and Experimental Medicine|July 2, 2015
Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot studyTomás Zambrano, Mario Hiroyuki Hirata, Álvaro Cerda, et al.
Clinical Cardiology|December 3, 2003
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroupsMichael H Davidson, Leiv Ose, Jiri Frohlich, et al.
Human Mutation|April 5, 2002
Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutationsLuis A Salazar, Mario H Hirata, Selma A Cavalli, et al.
Clinical Chemistry and Laboratory Medicine|November 29, 2005
APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individualsSimone C Sorkin, Francisco J Forestiero, Mario H Hirata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 7, 2013
Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal womenAlvaro Cerda, Mustafa H Issa, Fabiana D V Genvigir, et al.
Journal of Clinical Lipidology|May 6, 2014
Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjectsJacqueline M Anderson, Alvaro Cerda, Mario H Hirata, et al.
JAMA|June 22, 2002
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trialPatrick W J C Serruys, Pim de Feyter, Carlos Macaya, et al.
Pageof 5